Hormone News and Research

RSS

A hormone is a chemical released by one or more cells that affects cells in other parts of the organism. Only a small amount of hormone is required to alter cell metabolism. It is essentially a chemical messenger that transports a signal from one cell to another.

FDA approves OTREXUP injection for adults with RA, children with active pJIA

Antares Pharma, Inc. today announced the approval of OTREXUP (methotrexate) injection by the U.S. Food and Drug Administration. OTREXUP is the first FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.

14 Oct 2013

New less invasive surgical method paves way for development of efficient anti-obesity therapies

Bariatric surgeries, such as a gastric bypass, are currently the most effective anti-obesity therapies. They also lead to a reduced insulin resistance. However, the pitfall of these surgical interventions is that they are highly invasive and often permanent procedures.

11 Oct 2013

Researchers explore effects of soy, whey protein supplementation on hormonal responses to resistance exercise

A group of researchers recently expanded upon the limited prior research examining the effects of soy and whey protein supplementation on testosterone, sex hormone binding globulin (SHBG), and cortisol responses to an acute bout of resistance exercise.

11 Oct 2013

Genetic variation can affect how people see and experience the world

A new study by a University of British Columbia researcher finds that some people are genetically predisposed to see the world darkly.

11 Oct 2013

Drugs often fail to bring acromegaly under control in routine clinical practice

Over a quarter of UK patients treated for growth hormone-producing tumours do not achieve 'safe' growth hormone levels, according to a 30 year UK multi-centre study of clinical management of the rare disease acromegaly. The findings by the Society for Endocrinology UK Acromegaly Register, published in the November issue of Clinical Endocrinology, show that drugs to control acromegaly often fail to bring the disease completely under control in routine clinical practice.

10 Oct 2013

Recovery sleep over weekend may not reverse all effects of sleep lost during workweek

In many modern societies, adults often sacrifice sleep during the workweek to make time for other demands, then snooze longer on the weekends to recoup that lost sleep. Research has shown that even a few days of lost sleep can have adverse effects, including increased daytime sleepiness, worsened daytime performance, an increase in molecules that are a sign of inflammation in the body, and impaired blood sugar regulation.

10 Oct 2013

Compugen drug candidate prevents autoimmune type I diabetes in animal model

Compugen Ltd., announced today that CGEN-15001, an Fc fusion protein drug candidate derived from a novel immune checkpoint protein discovered by Compugen, has been shown to be highly efficient in preventing the development of disease in a well-accepted animal model of autoimmune type I diabetes, known also as juvenile diabetes.

9 Oct 2013

Widespread prescription of levothyroxine medication may cause more harm than good

A study of patients in the United Kingdom suggests widespread prescribing of the medication levothyroxine sodium to boost thyroid function among patients with borderline high levels of the thyroid-stimulating hormone thyrotropin (a sign of low thyroid function), raising the possibility of overtreatment, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

9 Oct 2013

Hypothyroidism linked to COPD exacerbation risk

Research shows that chronic obstructive pulmonary disease patients with hypothyroidism have an elevated exacerbation frequency but, despite this, experience similar quality of life to patients with normal thyroid function.

8 Oct 2013

Personalised therapy can reduce risk of cardiac disease among diabetes patients

600,000 to 800,000 Austrians suffer from diabetes mellitus. Thanks to the biomarker known as NT-proBNP (a hormone specific to the heart), the sub-group of people who are at increased risk of cardiovascular disease can be determined even though their hearts appear to be healthy.

8 Oct 2013

PMDD may shed light on complex interactions between sex hormones and mood

Improved understanding of the role of female sex hormones on the drivers and symptoms of premenstrual dysphoric disorder (PMDD) may shed light on the complex interactions between sex hormones and mood, potentially helping to explain the increased prevalence of mood disorders in women.

8 Oct 2013

Babies born to moms who smoked when pregnant have increased risk of nicotine addiction in adulthood

Adult women whose mothers had increased levels of stress hormones while they were pregnant are at greater risk of becoming addicted to nicotine, according to a new study led by a Miriam Hospital researcher.

8 Oct 2013

High levels of leptin in blood may increase risk of heart attack, stroke

High levels of adipose tissue hormone leptin in the blood reduces blood vessels' ability to dilate, and also affects blood clotting, all of which increase the risk of heart attack and stroke.

8 Oct 2013

Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting

Amgen today announced that it will present data from several romosozumab and Prolia® (denosumab) studies at the American Society for Bone and Mineral Research (ASBMR) 2013 Annual Meeting in Baltimore from Oct. 4-7, 2013.

5 Oct 2013

Study: Physical activity reduces risk of breast cancer in postmenopausal women

A large new American Cancer Society study adds to increasing evidence that physical activity reduces the risk of breast cancer in postmenopausal women. Researchers say moderate recreational activity was associated with a 14 percent lower risk and high physical activity with a 25 percent lower risk of breast cancer compared to women who were active at the lowest level.

4 Oct 2013

Certain mix of bacteria in vagina may play role in causing VVA in postmenopausal women

The mix of bacteria in the vagina changes as women go through menopause. And a certain mix is typical after menopause in women who have vulvovaginal atrophy (VVA), a common cause of vaginal dryness and sexual pain, finds a team at Johns Hopkins and the University of Maryland.

4 Oct 2013

Walking in woods reduces stress and boosts immune system

Work, home, even in the car, stress is a constant struggle for many people. But it's more than just exhausting and annoying. Unmanaged stress can lead to serious health conditions such as high blood pressure, heart disease, obesity and diabetes.

4 Oct 2013

Walking an hour per day associated with lower risk of breast cancer in women

Postmenopausal women who were very active or walked for at least seven hours a week had a reduced risk for breast cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

4 Oct 2013

Data analyses from Brisdelle Phase 3 pivotal trials to be showcased at NAMS' meeting

Noven Pharmaceuticals, Inc., today announced that 11 presentations, featuring data analyses from its Phase 3 pivotal trials that supported the recent U.S. Food and Drug Administration approval of Brisdelle (paroxetine capsules, 7.5 mg/day) for the treatment of moderate to severe vasomotor symptoms associated with menopause, will be showcased at the 2013 Annual Meeting of The North American Menopause Society in Dallas on Oct. 9-10.

2 Oct 2013

Laboratory testing kit that estimates risk of breast cancer relapse gets FDA approval

A laboratory testing kit that estimates the risk of breast cancer relapse in spite of anti-hormone treatment has received approval from the U.S. Food and Drug Administration.

2 Oct 2013

Hormone News and Research

Further Reading

FDA approves OTREXUP injection for adults with RA, children with active pJIA

New less invasive surgical method paves way for development of efficient anti-obesity therapies

Researchers explore effects of soy, whey protein supplementation on hormonal responses to resistance exercise

Genetic variation can affect how people see and experience the world

Drugs often fail to bring acromegaly under control in routine clinical practice

Recovery sleep over weekend may not reverse all effects of sleep lost during workweek

Compugen drug candidate prevents autoimmune type I diabetes in animal model

Widespread prescription of levothyroxine medication may cause more harm than good

Hypothyroidism linked to COPD exacerbation risk

Personalised therapy can reduce risk of cardiac disease among diabetes patients

PMDD may shed light on complex interactions between sex hormones and mood

Babies born to moms who smoked when pregnant have increased risk of nicotine addiction in adulthood

High levels of leptin in blood may increase risk of heart attack, stroke

Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting

Study: Physical activity reduces risk of breast cancer in postmenopausal women

Certain mix of bacteria in vagina may play role in causing VVA in postmenopausal women

Walking in woods reduces stress and boosts immune system

Walking an hour per day associated with lower risk of breast cancer in women

Data analyses from Brisdelle Phase 3 pivotal trials to be showcased at NAMS' meeting

Laboratory testing kit that estimates risk of breast cancer relapse gets FDA approval

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News